MK-7110
Biological
Merck Sharp & Dohme Corporation
Total Payments
$2.4M
Transactions
4
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $2.4M | 4 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $2.4M | 1 | 97.4% |
| Consulting Fee | $62,454 | 3 | 2.6% |
Top Doctors Receiving Payments for MK-7110
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Specialist | Washington, DC | $2.4M | 4 |
Ad
Manufacturing Companies
Product Information
- Type Biological
- Total Payments $2.4M
- Total Doctors 1
- Transactions 4
About MK-7110
MK-7110 is a biological associated with $2.4M in payments to 1 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Merck Sharp & Dohme Corporation.
Payment data is available from 2020 to 2020. In 2020, $2.4M was paid across 4 transactions to 1 doctors.
The most common payment nature for MK-7110 is "Royalty or License" ($2.4M, 97.4% of total).